INTANGIBLE ASSETS (Details Narrative) |
Mar. 31, 2026
USD ($)
|
Mar. 31, 2026
MYR (RM)
|
Jun. 30, 2025
USD ($)
|
|---|---|---|---|
| Intangible Asset, Finite-Lived [Line Items] | |||
| Finite lived assets | $ 33,665,611 | $ 33,503,771 | |
| Catalytic Biofraction Process [Member] | |||
| Intangible Asset, Finite-Lived [Line Items] | |||
| Finite lived assets | 30,192,771 | 30,192,771 | |
| License Catalytic Bio Fraction Process [Member] | |||
| Intangible Asset, Finite-Lived [Line Items] | |||
| Finite lived assets | $ 3,472,840 | RM 14,000,000 | $ 3,311,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|